Literature DB >> 3422749

Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

L Braun1, J E Mead, M Panzica, R Mikumo, G I Bell, N Fausto.   

Abstract

Transforming growth factor beta (TGF-beta) is a growth factor with multiple biological properties including stimulation and inhibition of cell proliferation. To determine whether TGF-beta is involved in hepatocyte growth responses in vivo, we measured the levels of TGF-beta mRNA in normal liver and during liver regeneration after partial hepatectomy in rats. TGF-beta mRNA increases in the regenerating liver and reaches a peak (about 8 times higher than basal levels) after the major wave of hepatocyte cell division and mitosis have taken place and after the peak expression of the ras protooncogenes. Although hepatocytes from normal and regenerating liver respond to TGF-beta, they do not synthesize TGF-beta mRNA. Instead, the message is present in liver nonparenchymal cells and is particularly abundant in cell fractions enriched for endothelial cells. TGF-beta inhibits epidermal growth factor-induced DNA synthesis in vitro in hepatocytes from normal or regenerating liver, although the dose-response curves vary according to the culture medium used. We conclude that TGF-beta may function as the effector of an inhibitory paracrine loop that is activated during liver regeneration, perhaps to prevent uncontrolled hepatocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422749      PMCID: PMC279808          DOI: 10.1073/pnas.85.5.1539

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation.

Authors:  D L Knook; E C Sleyster
Journal:  Exp Cell Res       Date:  1976-05       Impact factor: 3.905

Review 2.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

3.  Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta.

Authors:  R A Ignotz; T Endo; J Massagué
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

Review 4.  Transforming growth factors.

Authors:  A B Roberts; M B Sporn
Journal:  Cancer Surv       Date:  1985

5.  Developmental and tissue-specific expression of a family of transcripts related to rat insulin-like growth factor II mRNA.

Authors:  M B Soares; D N Ishii; A Efstratiadis
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

6.  Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.

Authors:  B I Carr; I Hayashi; E L Branum; H L Moses
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

7.  Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis.

Authors:  P Yaswen; M Goyette; P R Shank; N Fausto
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

8.  Sequence of a placental cDNA encoding the mouse insulin-like growth factor II precursor.

Authors:  M M Stempien; N M Fong; L B Rall; G I Bell
Journal:  DNA       Date:  1986-10

9.  Coordinate developmental regulation of high and low molecular weight mRNAs for rat insulin-like growth factor II.

Authors:  D E Graham; M M Rechler; A L Brown; R Frunzio; J A Romanus; C B Bruni; H J Whitfield; S P Nissley; S Seelig; S Berry
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Distribution and modulation of the cellular receptor for transforming growth factor-beta.

Authors:  L M Wakefield; D M Smith; T Masui; C C Harris; M B Sporn
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

View more
  109 in total

Review 1.  Differential growth: from carcinogenesis to liver repopulation.

Authors:  E Laconi
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors.

Authors:  A Francavilla; A Azzarone; G Carrieri; C Scotti-Foglieni; Q H Zeng; U Cillo; K Porter; T E Starzl
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

3.  Differential expression of guanine nucleotide-binding proteins enhances cAMP synthesis in regenerating rat liver.

Authors:  A M Diehl; S Q Yang; D Wolfgang; G Wand
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

4.  An experimental study on cell dynamic alteration in digestive organs following total parenteral nutrition in dogs.

Authors:  T Furumoto
Journal:  Gastroenterol Jpn       Date:  1992-08

Review 5.  Mitogens and hepatocyte growth control in vivo and in vitro.

Authors:  K S Koch; X P Lu; D A Brenner; G H Fey; A Martinez-Conde; H L Leffert
Journal:  In Vitro Cell Dev Biol       Date:  1990-11

6.  Sensitivity of the cell cycle to TGF beta 1 does not correlate with transformation of a rat liver epithelial cell line.

Authors:  R Davies; R F Legg; G E Neal
Journal:  Cell Biol Toxicol       Date:  1990-10       Impact factor: 6.691

7.  Mechanisms controlling growth of hepatocytes in primary culture.

Authors:  A Ichihara
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

8.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

9.  Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes.

Authors:  Seh-Hoon Oh; Marzena Swiderska-Syn; Mark L Jewell; Richard T Premont; Anna Mae Diehl
Journal:  J Hepatol       Date:  2018-05-23       Impact factor: 25.083

10.  Expression of HGF and TGF-beta 1 mRNA after partial hepatectomy in rats with liver cirrhosis.

Authors:  S Mitsue; M Hamanoue; G Tanabe; Y Ogura; S Yoshidome; T Aikou; T Nakamura
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.